Increasing kidney cancer incidence and survival in Estonia: role of age and stage

被引:10
作者
Innos, Kaire [1 ]
Sepp, Teesi [2 ]
Baburin, Aleksei [1 ]
Kotsar, Andres [2 ]
Lang, Katrin [3 ]
Padrik, Peeter [4 ,5 ]
Aareleid, Tiiu [1 ]
机构
[1] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Hiiu 42, EE-11619 Tallinn, Estonia
[2] Tartu Univ Hosp, Surg Clin, Dept Urol & Kidney Transplantat, Tartu, Estonia
[3] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia
[4] Tartu Univ Hosp, Clin Haematol & Oncol, Tartu, Estonia
[5] Univ Tartu, Inst Clin Med, Tartu, Estonia
关键词
RENAL-CELL CARCINOMA; INTERFERON-ALPHA; NORDIC COUNTRIES; BLOOD-PRESSURE; TRENDS; POPULATION; HYPERTENSION; METAANALYSIS; PREVALENCE; RISK;
D O I
10.1080/0284186X.2018.1512158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Kidney cancer rates in Estonia are high. The study aimed to examine long-term trends in kidney cancer incidence, mortality and survival in Estonia, with special focus on age, birth cohorts, morphology and TNM stage.Material and methods: Estonian Cancer Registry provided data on all incident cases of kidney cancer (ICD-10 C64), diagnosed in adults (age 15 years) in Estonia during 1995-2014. Relative survival ratios (RSR) were calculated and excess hazard ratios of dying were estimated with gender, age, period of diagnosis and TNM stage as independent variables. Joinpoint regression modeling was used to calculate estimated annual percentage change for incidence (1970-2014) and mortality (1995-2016) trends. Age-specific incidence rates were presented by birth cohort and period of diagnosis.Results: Incidence increased significantly in both sexes, with the steepest rise seen for localized cancer. Cohort effects were pronounced particularly in men, while period effects were seen from the mid-1980s to mid-1990s in both sexes. Age-standardized five-year RSR for total kidney cancer increased by 13 percentage units (from 53% to 65%) over the study period; the increase was larger for renal cell carcinoma (from 63% to 78%). Survival increases of about five percentage units were seen for stages I/II and III. Age and gender were not associated with excess risk of dying from renal cell carcinoma after adjusting for stage.Conclusion: Estonia is currently among countries with the highest incidence of kidney cancer. The results suggest a combined effect of changing risk profiles in successive birth cohorts and increasing diagnostic activity around 1990. Large survival increase can mostly be attributed to earlier detection, but improved diagnosis and treatment have probably influenced stage-specific survival. High proportion of tumors with unspecified morphology and those with unknown stage among the elderly warrants further investigation of diagnostic and treatment practices.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 51 条
  • [11] BERRINO F, 1999, IARC SCI PUBLICATION, V151
  • [12] Bray FCM., 2017, Cancer Incidence in Five Continents, VXI
  • [13] Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation computational realisation and applications
    Brenner, H
    Gefeller, O
    Hakulinen, T
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 326 - 335
  • [14] Cho E. Y., 2008, Textbook of cancer epidemiology, P597
  • [15] Analgesic use and the risk of kidney cancer: A meta-analysis of epidemiologic studies
    Choueiri, Toni K.
    Je, Youjin
    Cho, Eunyoung
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (02) : 384 - 396
  • [16] Epidemiology and risk factors for kidney cancer
    Chow, Wong-Ho
    Dong, Linda M.
    Devesa, Susan S.
    [J]. NATURE REVIEWS UROLOGY, 2010, 7 (05) : 245 - 257
  • [17] Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01
    Cífková, R
    Skodová, Z
    Lánská, V
    Adámková, V
    Novozámská, E
    Petrzílková, Z
    Jozífová, M
    Plásková, M
    Hejl, Z
    Palous, D
    Galovcová, M
    [J]. JOURNAL OF HYPERTENSION, 2004, 22 (08) : 1479 - 1485
  • [18] Standard cancer patient population for age standardising survival ratios
    Corazziari, I
    Quinn, M
    Capocaccia, R
    [J]. EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) : 2307 - 2316
  • [19] Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007
    De, Prithwish
    Otterstatter, Michael C.
    Semenciw, Robert
    Ellison, Larry F.
    Marrett, Loraine D.
    Dryer, Dagny
    [J]. CANCER CAUSES & CONTROL, 2014, 25 (10) : 1271 - 1281
  • [20] Estimating and modeling relative survival
    Dickman, Paul W.
    Coviello, Enzo
    [J]. STATA JOURNAL, 2015, 15 (01) : 186 - 215